Drug Shortage Report for ACT LEVOFLOXACIN

Last updated on 2018-11-08
Report ID 52485
Drug Identification Number 02315432
Brand name ACT LEVOFLOXACIN
Common or Proper name LEVOFLOXACIN
Company Name TEVA CANADA LIMITED
Active Ingredient(s) LEVOFLOXACIN
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code J01MA
ATC description QUINOLONE ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-04-15
Estimated end date 2019-01-30
Actual end date
Shortage status Actual shortage
Updated date 2018-11-08
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information